Lotilaner Ophthalmic Solution

Healio spoke with I. Paul Singh, MD, about treatment options available in dry eye.

The FDA approved Xdemvy, a 0.25% lotilaner ophthalmic solution, for the treatment of Demodex blepharitis, according to a press release from Tarsus Pharmaceuticals.

In these videos, Preeya K. Gupta, MD, FACS, associate professor of ophthalmology at Duke University, talks about the various treatment options for dry eye, both approved and in the pipeline, as well as challenges in diagnosis.